Sandbox chemo1: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 233: Line 233:
=== Miscellaneous ===
=== Miscellaneous ===


===== Antimitotic agent=====
* [[Eribulin|Eribulin (Halaven)]]
* [[Eribulin|Eribulin (Halaven)]]
* [[Ixabepilone|Ixabepilone (Ixempra)]]
* [[Ixabepilone|Ixabepilone (Ixempra)]]


===== Bisphosphonate =====
===== Bisphosphonates =====
* [[Zoledronic Acid|Zoledronic Acid (Zometa)]]
* [[Zoledronic Acid|Zoledronic Acid (Zometa)]]



Revision as of 22:15, 23 February 2015

Chemotherapeutic Agents by Category

Alkylating agents

Nitrogen mustards
Ethylenimines
Methylhydrazines
Alkylsulfonates
Nitrosoureas
Triazenes
Platinum coordination complexes

Antimetabolites

Folic acid analogs
Pyrimidine analogs
Purine analogs
Ribonucleotide reductase inhibitors

Natural products

Vinca alkaloids
Taxanes
Epipodophyllotoxins
Camptothecins
Antineoplastic antibiotics
Antineoplastic enzymes

Hormones and Antagonists

Adrenocortical suppressants
Adrenocortico-steroids
Progestins
Anti-estrogens
Aromatase inhibitors
Androgens
Anti-androgens
GnRH agonists
GnRH antagonists

Biologics

Monoclonal antibodies
Anti-CD20 antibodies
Anti-CD30 antibodies
Anti-CD33 antibodies
Anti-CD52 antibodies
Anti-CTLA–4 antibodies
Anti-EGFR (ErbB1) antibodies
Anti-PD–1 antibodies
Anti-HER2/neu (ErbB2) antibodies
Anti-VEGF antibodies
IL-2 inhibitors
IL-6 inhibitors
Immunotherapy

Hematopoietic Growth Factors

Erythrocyte growth factors
Granulocyte growth factors
Megakaryocyte growth factors

Supportive Medications

Chemotherapy protective agents
Antiemetic agents
RANK ligand inhibitors

Miscellaneous

Bisphosphonates
HDAC inhibitors
Hedgehog pathway inhibitors
Immunomodulatory drugs (IMiDs)
Kinase inhibitors
mTOR Inhibitors
Proteasome inhibitors
Radioactive agents
Somatostatin analogs
VEGF receptor-2 antagonists